These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6242389)

  • 1. Simplified method for purification of mouse beta 1H.
    Kaidoh T; Fujita T; Takata Y; Natsuume-Sakai S; Takahashi M
    Complement; 1984; 1(1):44-51. PubMed ID: 6242389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of bovine complement factor H.
    Mhatre A; Aston WP
    Vet Immunol Immunopathol; 1987 Apr; 14(4):357-75. PubMed ID: 2955562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification of the human complement control protein C3b inactivator.
    Crossley LG; Porter RR
    Biochem J; 1980 Oct; 191(1):173-82. PubMed ID: 6451220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3b.
    Kazatchkine MD; Fearon DT; Silbert JE; Austen KF
    J Exp Med; 1979 Nov; 150(5):1202-15. PubMed ID: 501288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine C4-binding protein: a rapid purification method by affinity chromatography.
    Kaidoh T; Natsuume-Sakai S; Takahashi M
    J Immunol; 1981 Feb; 126(2):463-7. PubMed ID: 6161173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and structural studies on the complement-system control protein beta 1H (Factor H).
    Sim RB; DiScipio RG
    Biochem J; 1982 Aug; 205(2):285-93. PubMed ID: 6215918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and quantitation of the components of the alternative complement pathway.
    Minta JO; Gee AP
    Methods Enzymol; 1983; 93():375-408. PubMed ID: 6223199
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulatory proteins for the activated third and fourth components of complement (C3b and C4b) in mice. I. Isolation and characterization of factor H: the serum cofactor for the C3b/C4b inactivator (factor I).
    Kinoshita T; Nussenzweig V
    J Immunol Methods; 1984 Jul; 71(2):247-57. PubMed ID: 6376638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction of C3b bound to pneumococci with factor H (beta 1H globulin), factor I (C3b/C4b inactivator), and properdin factor B of the human complement system.
    Brown EJ; Joiner KA; Gaither TA; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):409-15. PubMed ID: 6223077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The separation of functionally distinct forms of the third component of human complement (C3).
    Parkes C; DiScipio RG; Kerr MA; Prohaska R
    Biochem J; 1981 Mar; 193(3):963-70. PubMed ID: 6458280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse C3b/C4b inactivator: purification and properties.
    Kai S; Fujita T; Gigli I; Nussenzweig V
    J Immunol; 1980 Dec; 125(6):2409-15. PubMed ID: 6776193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H.
    Meri S; Pangburn MK
    Proc Natl Acad Sci U S A; 1990 May; 87(10):3982-6. PubMed ID: 1692629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation, characterization, and mechanism of action of rat beta 1H.
    Daha MR; van Es LA
    J Immunol; 1982 Apr; 128(4):1839-43. PubMed ID: 6460812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of rabbit H of the alternative complement pathway.
    Nakano Y; Tobe T; Matsuda T; Sakamoto T; Tomita M
    J Biochem; 1984 May; 95(5):1469-75. PubMed ID: 6746616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of human C3b inactivator by monoclonal-antibody affinity chromatography.
    Hsiung L; Barclay AN; Brandon MR; Sim E; Porter RR
    Biochem J; 1982 Apr; 203(1):293-8. PubMed ID: 7103942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the mechanism of recognition in the complement alternative pathway using C3b-bound low molecular weight polysaccharides.
    Pangburn MK
    J Immunol; 1989 Apr; 142(8):2759-65. PubMed ID: 2467938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human complement factor H: an additional gene product of 43 kDa isolated from human plasma shows cofactor activity for the cleavage of the third component of complement.
    Misasi R; Huemer HP; Schwaeble W; Sölder E; Larcher C; Dierich MP
    Eur J Immunol; 1989 Sep; 19(9):1765-8. PubMed ID: 2529127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of two molecular populations of human complement factor H by hydrophobic affinity chromatography.
    Ripoche J; Al Salihi A; Rousseaux J; Fontaine M
    Biochem J; 1984 Jul; 221(1):89-96. PubMed ID: 6235808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A low molecular weight inhibitor of the alternative complement pathway. I. Its isolation from human urine and the reaction mechanism.
    Nagaki K; Matsumoto M; Kitamura H
    Immunology; 1980 Dec; 41(4):789-98. PubMed ID: 6450726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the lymphocyte membrane receptor for factor H (beta 1H-globulin) with an antibody to anti-factor H idiotype.
    Lambris JD; Ross GD
    J Exp Med; 1982 May; 155(5):1400-11. PubMed ID: 6461713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.